nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cancer immunotherapy: Are we there yet?
|
Sredni, Benjamin |
|
2012 |
22 |
1 |
p. 1-2 2 p. |
artikel |
2 |
Cancer-related inflammation: Common themes and therapeutic opportunities
|
Balkwill, Frances R. |
|
2012 |
22 |
1 |
p. 33-40 8 p. |
artikel |
3 |
Editorial Board
|
|
|
2012 |
22 |
1 |
p. CO2- 1 p. |
artikel |
4 |
Genetically modulating T-cell function to target cancer
|
Merhavi-Shoham, Efrat |
|
2012 |
22 |
1 |
p. 14-22 9 p. |
artikel |
5 |
Immunomodulating tellurium compounds as anti-cancer agents
|
Sredni, Benjamin |
|
2012 |
22 |
1 |
p. 60-69 10 p. |
artikel |
6 |
Inflammation and immune surveillance in cancer
|
Chow, Melvyn T. |
|
2012 |
22 |
1 |
p. 23-32 10 p. |
artikel |
7 |
MicroRNAs and STAT interplay
|
Kohanbash, Gary |
|
2012 |
22 |
1 |
p. 70-75 6 p. |
artikel |
8 |
Monoclonal antibodies for the treatment of cancer
|
Shuptrine, Casey W. |
|
2012 |
22 |
1 |
p. 3-13 11 p. |
artikel |
9 |
Neoplastic “Black Ops”: Cancer's subversive tactics in overcoming host defenses
|
Biragyn, Arya |
|
2012 |
22 |
1 |
p. 50-59 10 p. |
artikel |
10 |
Targeting stroma to treat cancers
|
Engels, Boris |
|
2012 |
22 |
1 |
p. 41-49 9 p. |
artikel |